Display options
Share it on

J Matern Fetal Neonatal Med. 2019 Apr 09;1-8. doi: 10.1080/14767058.2019.1588876. Epub 2019 Apr 09.

Prenatal opioid exposure heightens sympathetic arousal and facial expressions of pain/distress in term neonates at 24-48 hours post birth.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Christiana N Oji-Mmuo, Rebecca R Speer, Fumiyuki C Gardner, Megan M Marvin, Alexia C Hozella, Kim K Doheny

Affiliations

  1. a Department of Pediatrics, Division of Neonatal-Perinatal Medicine , Penn State Health Children's Hospital , Hershey , PA , USA.
  2. b Department of Pediatrics , Penn State College of Medicine , Hershey , PA , USA.
  3. c Department of Neural and Behavioral Sciences , Penn State College of Medicine , Hershey , PA , USA.

PMID: 30821185 PMCID: PMC7197408 DOI: 10.1080/14767058.2019.1588876

Abstract

PURPOSE: The rising issue of opioid use during pregnancy poses an increased risk of fetal exposure to opioids in-utero and the development of neonatal abstinence syndrome (NAS). The cessation of exposure to opioids upon birth causes elevated levels of norepinephrine in the circulation enhancing sympathetic arousal. Skin conductance (SC) detects sympathetic-mediated sweating while the Neonatal Facial Coding System (NFCS) depicts facial expressions of stress and pain. We hypothesize that there will be a direct correlation between SC and NFCS scores, such that neonates with prenatal opioid exposure will have higher SC and facial responses to pain/stress as compared with healthy neonates without prenatal opioid exposure.

OBJECTIVE: This study evaluates the utility of SC and the NFCS in the objective assessment of early postnatal pain response in opioid-exposed and non-opioid exposed neonates.

METHODS: This prospective, single-center, pilot study enrolled opioid-exposed term neonates (>37 weeks) and healthy controls. Subjects were observed within 24-48 hours post-birth (and prior to opioid withdrawal) for pain at baseline, during, and post-heel lance/squeeze (HLS) with simultaneously measured SC and videotaped facial expressions. SC data included electro-dermal responses over time (EDR/second) and the average amplitude of responses (mean of peaks [MP]). Video data were scored using the NFCS by two trained coders with inter-rater agreement >85%.

RESULTS: SC and NFCS scores were significantly associated with both groups. The opioid-exposed neonates had significantly higher skin conductance indices, EDR/sec for the HLS phase, and MP for HLS and post phases as compared with controls (p < .05). Opioid-exposed neonates demonstrated higher NFCS at baseline (p = .003).

CONCLUSIONS: Prenatal opioid exposure was associated with heightened sympathetic arousal during both pain and recovery phases and higher facial expressions of pain/distress at baseline only. A multimodal system of assessment may be useful in understanding the complexity and severity of opioid withdrawal associated with NAS.

Keywords: Neonatal Facial Coding System; Neonatal abstinence syndrome; neonatal opioid withdrawal; neonatal pain; skin conductance

References

  1. Curr Opin Pediatr. 2012 Apr;24(2):252-8 - PubMed
  2. Addict Dis. 1975;2(1-2):141-58 - PubMed
  3. Pain. 1987 Mar;28(3):395-410 - PubMed
  4. Acta Paediatr. 2016 Mar;105(3):e99-e106 - PubMed
  5. Pediatrics. 2004 Jul;114(1):65-72 - PubMed
  6. Pediatrics. 2000 Feb;105(2):454-61 - PubMed
  7. Arch Dis Child Fetal Neonatal Ed. 2000 Sep;83(2):F143-7 - PubMed
  8. J Matern Fetal Neonatal Med. 2018 Dec;31(23):3209-3213 - PubMed
  9. J Pediatr. 1977 Oct;91(4):638-41 - PubMed
  10. Acta Paediatr. 2008 Jan;97(1):27-30 - PubMed
  11. Clin Pediatr (Phila). 1975 Jun;14(6):592-4 - PubMed
  12. Pain. 1998 Jun;76(3):277-86 - PubMed
  13. J Pain. 2009 Feb;10(2):214-20 - PubMed
  14. Brain Res Brain Res Rev. 2001 Dec;38(1-2):1-19 - PubMed
  15. Res Nurs Health. 2009 Aug;32(4):465-74 - PubMed
  16. Psychophysiology. 2013 Jan;50(1):15-22 - PubMed
  17. Brain Res Bull. 2018 Apr;138:106-111 - PubMed
  18. Front Pediatr. 2017 Sep 20;5:204 - PubMed
  19. Eur J Pediatr. 2016 Jun;175(6):859-68 - PubMed
  20. Clin J Pain. 2008 Jul-Aug;24(6):479-96 - PubMed
  21. J Matern Fetal Neonatal Med. 2013 Sep;26(14):1399-403 - PubMed
  22. Arch Dis Child Fetal Neonatal Ed. 2016 Jan;101(1):F26-30 - PubMed
  23. J Dev Behav Pediatr. 1998 Apr;19(2):89-93 - PubMed
  24. Early Hum Dev. 2011 Jan;87(1):37-42 - PubMed
  25. Early Hum Dev. 2006 Sep;82(9):603-8 - PubMed
  26. Pain. 2008 Aug 31;138(2):460-71 - PubMed
  27. Clin J Pain. 2007 Jun;23(5):417-24 - PubMed
  28. J Perinatol. 2015 Aug;35(8):650-5 - PubMed
  29. Pediatrics. 2012 Feb;129(2):e540-60 - PubMed
  30. Arch Dis Child Fetal Neonatal Ed. 2016 Jan;101(1):F2-3 - PubMed
  31. J Matern Fetal Neonatal Med. 2012 Jun;25(6):796-801 - PubMed
  32. Pediatrics. 2014 Aug;134(2):e547-61 - PubMed
  33. Early Hum Dev. 2013 Mar;89(3):153-8 - PubMed
  34. J Matern Fetal Neonatal Med. 2016;29(15):2531-6 - PubMed
  35. Res Nurs Health. 1990 Oct;13(5):311-8 - PubMed
  36. N Engl J Med. 2016 Dec 22;375(25):2468-2479 - PubMed
  37. Paediatr Anaesth. 2013 Aug;23(8):761-3 - PubMed
  38. Arch Pediatr Adolesc Med. 2001 Feb;155(2):173-80 - PubMed

Publication Types

Grant support